ReShape Lifesciences Inc.’s recently made public that its Chief Financial Officer STANKOVICH THOMAS unloaded Company’s shares for reported $12.0 on May 31 ’24. In the deal valued at $0.25 per share,48 shares were sold. As a result of this transaction, STANKOVICH THOMAS now holds 22,777 shares worth roughly $3644.32.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, STANKOVICH THOMAS sold 42 shares, generating $10 in total proceeds. Upon selling the shares at $0.25, the Chief Financial Officer now owns 22,868 shares.
Before that, STANKOVICH THOMAS sold 39 shares. ReShape Lifesciences Inc. shares valued at $9 were divested by the Chief Financial Officer at a price of $0.23 per share. As a result of the transaction, STANKOVICH THOMAS now holds 22,910 shares, worth roughly $3665.6.
Price Performance Review of RSLS
On Tuesday, ReShape Lifesciences Inc. [NASDAQ:RSLS] saw its stock fall -0.86% to $0.16. Over the last five days, the stock has gained 7.47%. ReShape Lifesciences Inc. shares have fallen nearly -35.44% since the year began. Nevertheless, the stocks have fallen -78.36% over the past one year. While a 52-week high of $0.78 was reached on 05/29/24, a 52-week low of $0.14 was recorded on 02/14/24. SMA at 50 days reached $0.1833, while 200 days put it at $0.1984.
Levels Of Support And Resistance For RSLS Stock
The 24-hour chart illustrates a support level at 0.1539, which if violated will result in even more drops to 0.1465. On the upside, there is a resistance level at 0.1730. A further resistance level may holdings at 0.1847. The Relative Strength Index (RSI) on the 14-day chart is 45.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0067, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.21%. Stochastics %K at 59.24% indicates the stock is a holding.
How much short interest is there in ReShape Lifesciences Inc.?
A steep rise in short interest was recorded in ReShape Lifesciences Inc. stocks on 2024-08-30, dropping by 94792.0 shares to a total of 0.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 0.68 million shares. There was a decline of -16.2%, which implies that there is a negative sentiment for the stock.